Dennis J. Slamon

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.9Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

Nature Communications(2020)10.1038/s41467-020-19494-2

Top 9%

2.3DataRank

Top 9%66 citations

Jennifer L. Caswell‐Jin, Katherine McNamara, Jason J. Zoeller, Gregory R. Bean, Robert Dichmann +20 more

Papers

Driven by 16 papers — median percentile 78. Top paper: “Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)”.

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

Nature Communications(2020)10.1038/s41467-020-19494-2

Top 9%

2.3DataRank

Top 9%66 citations

Jennifer L. Caswell‐Jin, Katherine McNamara, Jason J. Zoeller, Gregory R. Bean, Robert Dichmann +20 more

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0103

N/A

1.8DataRank · unranked

76 citations

Joshy George, Chen Wang, Timothy Budden, Tuan Zea Tan, Derek S. Chiu +134 more

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

New England Journal of Medicine(2001)10.1056/nejm200103153441101

N/A

1.4DataRank · unranked

11469 citations

Brian Leyland-Jones, Steven Shak, Hank Fuchs, Virginia Paton, Alex Bajamonde +11 more

Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

Science(1989)10.1126/science.2470152

N/A

1.3DataRank · unranked

6845 citations

William Godolphin, Lovell A. Jones, John A. Holt, Steven G. Wong, Duane E. Keith +7 more

Cycling cancer persister cells arise from lineages with distinct programs

Nature(2021)10.1038/s41586-021-03796-6

N/A

0.933DataRank · unranked

502 citations

Michael Tsabar, Michael S. Cuoco, Liat Amir-Zilberstein, Jan-Christian Hütter, Bomiao Hu +18 more

Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma

The American Journal of Pathology(2009)10.2353/ajpath.2009.081000

N/A

0.926DataRank · unranked

479 citations

Tsui-Lien Mao, Siân Jones, Emanuela Veras, Ayse Ayhan, Tian-Li Wang +10 more

Prognostic gene expression signature for high-grade serous ovarian cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.05.019

N/A

0.718DataRank · unranked

119 citations

S. Chen, Blake Gilks, C. Wang, S.C.Y. Leung, V. Chow +387 more

Large-scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.03.186908

Top 34%

0.578DataRank

Top 34%10 citations

Jun Li, Mei‐Ju Chen, Zhenlin Ju, Nicole K. Nesser, Katie Johnson-Camacho +20 more

Cycling cancer persister cells arise from lineages with distinct transcriptional and metabolic programs

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.05.136358

N/A

0.312DataRank · unranked

7 citations

Michael Tsabar, Michael S. Cuoco, Elma Zaganjor, Pratiksha I. Thakore, Marcin Tabaka +9 more

Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.102028

N/A

0.301DataRank · unranked

6 citations

Tara M. Davidson, Coriolan Lebreton, Leah A. Marsh, Deandra K. Chetram, Hunter J. Atkinson +14 more

Circulating tumor DNA (ctDNA) mutations may predict treatment response in extensive-stage small cell lung cancer (ES-SCLC) treated with talazoparib and temozolomide (TMZ).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8564

N/A

0DataRank · unranked

2 citations

Amy L. Cummings, Melody Mendenhall, David E. Kanamori, Andrew Nguyen, David Dae-Young Kim +12 more

Integrative transcriptomics and cell systems analyses reveal protective pathways controlled by Igfbp‐3 in anthracycline‐induced cardiotoxicity

The FASEB Journal(2023)10.1096/fj.202201885rr

N/A

0DataRank · unranked

8 citations

Douglas J. Chapski, Jeremy Jong, Jerome Awada, Yijie Wang, Dennis J. Slamon +3 more

Data from Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

(2023)10.1158/1078-0432.c.6530603

N/A

0DataRank · unranked

0 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

Data from Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

(2023)10.1158/1078-0432.c.6530603.v1

N/A

0DataRank · unranked

0 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0393

N/A

0DataRank · unranked

55 citations

Akshaya V. Annapragada, Pien Lof, Sarah Short, Adrianna L. Bartolomucci, Dimitrios Mathios +30 more

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-19-4191

N/A

0DataRank · unranked

94 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

Dennis J. Slamon

Indexed papers

Top data-sharing exemplar

Papers